Patents by Inventor Ian C. P. Smith

Ian C. P. Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8404487
    Abstract: Robust classification methods analyse magnetic resonance spectroscopy (MRS) data (spectra) of fine needle aspirates taken from breast tumors. The resultant data when compared with the histopathology and clinical criteria provide computerized classification-based diagnosis and prognosis with a very high degree of accuracy and reliability. Diagnostic correlation performed between the spectra and standard synoptic pathology findings contain detail regarding the pathology (malignant versus benign), vascular invasion by the primary cancer and lymph node involvement of the excised axillary lymph nodes. The classification strategy consisted of three stages: pre-processing of MR magnitude spectra to identify optimal spectral regions, cross-validated Linear Discriminant Analysis, and classification aggregation via Computerised Consensus Diagnosis. Malignant tissue was distinguished from benign lesions with an overall accuracy of 93%.
    Type: Grant
    Filed: February 26, 2008
    Date of Patent: March 26, 2013
    Inventors: Carolyn E. Mountford, Peter Russell, Ian C. P. Smith, Rajmund L. Somorjai
  • Patent number: 7335511
    Abstract: Robust classification methods analyze magnetic resonance spectroscopy (MRS) data (spectra) of fine needle aspirates taken from breast tumors. The resultant data when compared with the histopathology and clinical criteria provide computerized classification-based diagnosis and prognosis with a very high degree of accuracy and reliability. Diagnostic correlation performed between the spectra and standard synoptic pathology findings contain detail regarding the pathology (malignant versus benign), vascular invasion by the primary cancer and lymph node involvement of the excised axillary lymph nodes. The classification strategy consisted of three stages: pre-processing of MR magnitude spectra to identify optimal spectral regions, cross-validated Linear Discriminant Analysis, and classification aggregation via Computerised Consensus Diagnosis. Malignant tissue was distinguished from benign lesions with an overall accuracy of 93%.
    Type: Grant
    Filed: December 15, 2004
    Date of Patent: February 26, 2008
    Assignees: University of Sydney, National Research Council of Canada
    Inventors: Carolyn E. Mountford, Peter Russell, Ian C. P. Smith, Rajmund L. Somorjai
  • Patent number: 6835572
    Abstract: Robust classification methods analyse magnetic resonance spectroscopy (MRS) data (spectra) of fine needle aspirates taken from breast tumours. The resultant data when compared with the histopathology and clinical criteria provide computerized classification-based diagnosis and prognosis with a very high degree of accuracy and reliability. Diagnostic correlation performed between the spectra and standard synoptic pathology findings contain detail regarding the pathology (malignant versus benign), vascular invasion by the primary cancer and lymph node involvement of the excised axillary lymph nodes. The classification strategy consisted of three stages: pre-processing of MR magnitude spectra to identify optimal spectral regions, cross-validated Linear Discriminant Analysis, and classification aggregation via Computerised Consensus Diagnosis. Malignant tissue was distinguished from benign lesions with an overall accuracy of 93%.
    Type: Grant
    Filed: October 18, 2000
    Date of Patent: December 28, 2004
    Assignees: Institute for Magnetic Resonance Research, National Research Council of Canada
    Inventors: Carolyn E. Mountford, Peter Russell, Ian C. P. Smith, Rajmund L. Somorjai
  • Patent number: 6821784
    Abstract: Two dimensional COSY magnetic resonance spectroscopy of human stool can be used in a non-invasive method of detecting the presence of colorectal cancer. The spectrum of a patient's stool is compared with that of stool from non-cancerous subjects, observed differences in spectra being indicative of cancer.
    Type: Grant
    Filed: November 16, 2001
    Date of Patent: November 23, 2004
    Assignees: The University of Manitoba, National Research Council of Canada, Board of Regents, University of Texas System
    Inventors: Tedros Bezabeh, Ian C. P. Smith, Charles Noah Bernstein, Bernard Levin, Constance Johnson